157 related articles for article (PubMed ID: 33235141)
1. Current Salvage Treatment Strategies for Younger Children (<10 y of Age) With Progressive Low-grade Glioma After Initial Chemotherapy in North America: A Web-based Survey.
Moorman B; Barbour M; Huang MA
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e141-e145. PubMed ID: 33235141
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
Nellan A; Wright E; Campbell K; Davies KD; Donson AM; Amani V; Judd A; Hemenway MS; Raybin J; Foreman NK; Rush S; Dorris K
J Neurooncol; 2020 Jul; 148(3):569-575. PubMed ID: 32506370
[TBL] [Abstract][Full Text] [Related]
3. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.
Gnekow AK; Falkenstein F; von Hornstein S; Zwiener I; Berkefeld S; Bison B; Warmuth-Metz M; Driever PH; Soerensen N; Kortmann RD; Pietsch T; Faldum A
Neuro Oncol; 2012 Oct; 14(10):1265-84. PubMed ID: 22942186
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of Bevacizumab Activity, and Maintenance of Efficacy in Retreatment After Subsequent Relapse, in Pediatric Low-grade Glioma.
Kalra M; Heath JA; Kellie SJ; Dalla Pozza L; Stevens MM; Swamy S; McCowage GB
J Pediatr Hematol Oncol; 2015 Aug; 37(6):e341-6. PubMed ID: 26056795
[TBL] [Abstract][Full Text] [Related]
6. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
Gnekow AK; Walker DA; Kandels D; Picton S; Giorgio Perilongo ; Grill J; Stokland T; Sandstrom PE; Warmuth-Metz M; Pietsch T; Giangaspero F; Schmidt R; Faldum A; Kilmartin D; De Paoli A; De Salvo GL;
Eur J Cancer; 2017 Aug; 81():206-225. PubMed ID: 28649001
[TBL] [Abstract][Full Text] [Related]
7. Transient Hepatotoxicity Induced by Vinblastine in a Young Girl with Chiasmatic Low Grade Glioma.
Franke NE; Blok GJ; Voll ML; Schouten-van Meeteren AYN
Curr Drug Saf; 2020; 15(3):231-235. PubMed ID: 32682382
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.
Bouffet E; Jakacki R; Goldman S; Hargrave D; Hawkins C; Shroff M; Hukin J; Bartels U; Foreman N; Kellie S; Hilden J; Etzl M; Wilson B; Stephens D; Tabori U; Baruchel S
J Clin Oncol; 2012 Apr; 30(12):1358-63. PubMed ID: 22393086
[TBL] [Abstract][Full Text] [Related]
9. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
[TBL] [Abstract][Full Text] [Related]
10. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
Packer RJ; Ater J; Allen J; Phillips P; Geyer R; Nicholson HS; Jakacki R; Kurczynski E; Needle M; Finlay J; Reaman G; Boyett JM
J Neurosurg; 1997 May; 86(5):747-54. PubMed ID: 9126887
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin and vincristine neurotoxicity in the treatment of pediatric low-grade gliomas.
Rosca L; Robert-Boire V; Delisle JF; Samson Y; Perreault S
Pediatr Blood Cancer; 2018 Nov; 65(11):e27351. PubMed ID: 30014595
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
Scheinemann K; Bartels U; Tsangaris E; Hawkins C; Huang A; Dirks P; Fried I; Bouffet E; Tabori U
Pediatr Blood Cancer; 2011 Jul; 57(1):84-8. PubMed ID: 21557457
[TBL] [Abstract][Full Text] [Related]
14. Salvage chemotherapy after failure of targeted therapy in a child with BRAF V600E low-grade glioma.
Raswoli M; Nobre L; Hawkins C; Bartels UK; Tabori U; Bouffet E
Pediatr Blood Cancer; 2021 Jan; 68(1):e28561. PubMed ID: 32681754
[No Abstract] [Full Text] [Related]
15. Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas.
Lancaster DL; Hoddes JA; Michalski A
J Neurooncol; 2003 Jul; 63(3):289-94. PubMed ID: 12892235
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO-grade II-Report from the German/Swiss SIOP-LGG 2004 cohort.
Falkenstein F; Gessi M; Kandels D; Ng HK; Schmidt R; Warmuth-Metz M; Bison B; Krauss J; Kortmann RD; Timmermann B; Thomale UW; Albert MH; Pekrun A; Maaß E; Gnekow AK; Pietsch T
Int J Cancer; 2020 Oct; 147(8):2159-2175. PubMed ID: 32239677
[TBL] [Abstract][Full Text] [Related]
17. Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey.
Azizi AA; Schouten-van Meeteren AYN
J Neurooncol; 2018 Jan; 136(1):127-134. PubMed ID: 29071540
[TBL] [Abstract][Full Text] [Related]
18. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group.
Ater JL; Zhou T; Holmes E; Mazewski CM; Booth TN; Freyer DR; Lazarus KH; Packer RJ; Prados M; Sposto R; Vezina G; Wisoff JH; Pollack IF
J Clin Oncol; 2012 Jul; 30(21):2641-7. PubMed ID: 22665535
[TBL] [Abstract][Full Text] [Related]
19. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.
Ronghe M; Hargrave D; Bartels U; Tabori U; Vaidya S; Chandler C; Kulkarni A; Bouffet E
Pediatr Blood Cancer; 2010 Sep; 55(3):471-7. PubMed ID: 20535831
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.
Lafay-Cousin L; Sung L; Carret AS; Hukin J; Wilson B; Johnston DL; Zelcer S; Silva M; Odame I; Mpofu C; Strother D; Bouffet E
Cancer; 2008 Feb; 112(4):892-9. PubMed ID: 18098210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]